Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 2.41
-23 %
$ 119 M
Market Cap
-2.06
P/E
BALANCE SHEET
180 M
ASSETS
127 M
LIABILITIES
53.8 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Akoya Biosciences, Inc.
| Current Assets | 122 M |
| Cash & Short-Term Investments | 83.1 M |
| Receivables | 17 M |
| Other Current Assets | 21.7 M |
| Non-Current Assets | 58.6 M |
| Long-Term Investments | 0 |
| PP&E | 20.7 M |
| Other Non-Current Assets | 37.9 M |
| Current Liabilities | 35.3 M |
| Accounts Payable | 11.8 M |
| Short-Term Debt | 6.9 M |
| Other Current Liabilities | 16.7 M |
| Non-Current Liabilities | 91.3 M |
| Long-Term Debt | 82.3 M |
| Other Non-Current Liabilities | 9 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 83.1 | 74.2 | 113.1 | 17.0 | 11.6 |
| Short Term Investments | 0 | 7.0 | 0 | 0 | 10.0 |
| Receivables | 17.0 | 9.7 | 9.4 | 6.5 | 13.2 |
| Inventory | 17.9 | 14.5 | 9.0 | 4.3 | 4.1 |
| Other Current Assets | 3.8 | 6.8 | 13.5 | 1.0 | 2.0 |
| Total Current Assets | 121.8 | 112.2 | 140.8 | 28.7 | 40.9 |
| PP&E | 20.7 | 22.4 | 7.5 | 5.5 | 5.0 |
| Intangible Assets | 17.4 | 20.0 | 21.1 | 22.7 | 24.1 |
| Goodwill | 18.3 | 18.3 | 18.3 | 18.3 | 18.3 |
| Long Term Investments | 0 | 0.3 | 0.3 | 0.5 | 0.5 |
| Other Long Term Assets | 2.2 | 3.1 | 3.2 | 2.5 | 1.2 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 180.4 | 176.0 | 190.9 | 77.7 | 89.4 |
| LIABILITIES | |||||
| Accounts Payable | 11.8 | 10.6 | 9.4 | 5.1 | 8.1 |
| Short Term Debt | 6.9 | 7.3 | 0.5 | 1.2 | 80 K |
| Other Current Liabilities | 10.0 | 12.9 | 13.2 | 7.0 | 8.6 |
| Total Current Liabilities | 35.3 | 37.1 | 27.7 | 17.2 | 21.2 |
| Long Term Debt | 82.3 | 72.2 | 32.7 | 33.8 | 24.7 |
| Deferred Tax Income | 38 K | 87 K | 26 K | 0.2 | 0.2 |
| Other Liabilities | 5.8 | 6.0 | 7.8 | 7.0 | 72.7 |
| Total Liabilities | 126.6 | 117.5 | 69.6 | 59.1 | 119.6 |
| EQUITY | |||||
| Common Stock | 2 K | 2 K | 2 K | 2 K | 1 K |
| Retained Earnings | (230.1) | (166.7) | (96.1) | (52.3) | (31.4) |
| Other Accumulative Comprehensive Income/Loss | 0 | 6 K | (190.9) | (70.4) | 1 K |
| Total Equity | 53.8 | 58.6 | 121.4 | 18.6 | (30.2) |
| Total Liabilities and Equity | 180.4 | 176.0 | 190.9 | 77.7 | 89.4 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 44.4 | 37.7 | 37.4 | 37.1 | 37.1 |